The 25th Annual Meeting of the Japanese Society for Regenerative Medicine (JSRM) will be held on March 19–20, 2026, at the Kobe International Conference Center and Kobe International Exhibition Hall.

We are pleased to announce that Yuki Yamamoto, CEO of HiLung, will be speaking at a sponsored scientific seminar on March 20.
LS-19 | Friday, March 20, 12:00–12:50
Room 9, Kobe International Conference Center, 4F, Room 403
Sponsored Scientific Seminar (Luncheon Seminar 19)
Improving Reproducibility and Culture Efficiency for Drug Discovery Applications of Organoids Chair:
Kazunori Fujimoto
(Daiichi Sankyo Co., Ltd., Safety Research Laboratories)
Presentations:
LS-19-1
Application of Human iPSC-Derived Lung Organoids to Predictive Pulmonary Toxicity Testing
Yuki Yamamoto (HiLung Inc.)

HiLung has been engaged in both contract research and collaborative projects with partners in Japan and overseas for the evaluation of drug-induced lung toxicity.
At this seminar, we will showcase how our unique alveolar organoid and alveolar macrophage platforms can be applied to pulmonary toxicity assessment and translational drug discovery.
Join us to learn how HiLung’s human iPSC-derived lung platforms are advancing the future of pulmonary toxicity testing and respiratory drug discovery.